Finney Elisha W reported option exercise involving 65 derivative units of ICU MEDICAL INC DE at $0.00 for $0 on Nov 12, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 13, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
65Non-Qualified Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,700Direct
Trade date
Nov 12, 2026Option exercise
Filed
Nov 13, 2026, 4:28 PM ET1-day reporting delay
Accession
0001217439-26-000004Code M · Transaction 400722
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Sell65$179.00−$11,635Trade 400719
Nov 13, 2026Sell1,700$179.00−$304,300Trade 400721
Nov 13, 2026Option exercise1,700$0.00$0Trade 400723
Nov 12, 2026Option exercise65$158.20$10,283Trade 400718
Nov 13, 2026Option exercise1,700$158.20$268,940Trade 400720
6 transaction rows in this filing. Joint filers share the same rows.

ICUI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ICUI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −1.9%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: All shares sold were sold at the exact price disclosed.